Under the agreement, the companies are working closely to provide support for HiSeq X Ten whole-genome workflows and analysis pipelines, including those to be used inside of Illumina. Additionally, Illumina will be using GenoLogics’ LIMS to support its collaboration with Genomics England to sequence 100,000 genomes.
The agreement pairs the $1,000 genome with the preeminent laboratory information management system, further empowering the sequencing community to sequence human whole genomes.
According to Alex Dickinson, Senior Vice President of Strategic Initiatives at Illumina, “Illumina is pleased to be working with GenoLogics to ensure HiSeq X Ten customers receive the LIMS support they need. Scaling a lab to deliver the $1,000 genome presents unique challenges and GenoLogics has the demonstrated ability and understanding of our technologies to support these labs.”
“Clarity LIMS leads the industry because it helps sequencing labs improve overall efficiency, turnaround time, and the accuracy of data,” states Michael Ball, CEO of GenoLogics. “This agreement was the logical next step with Illumina because it builds on these efficiencies with enhanced automation and throughput, enabling customers to rapidly scale their sequencing operations.”